Experienced in Hydronephrosis

Ryuji Matsumoto

Sapporo, JP 
Experienced in Hydronephrosis
Sapporo, JP 
OverviewLocationsClinical Research

Overview

Ryuji Matsumoto practices in Sapporo, Japan. Mr. Matsumoto is rated as an Experienced expert by MediFind in the treatment of Hydronephrosis. His top areas of expertise are Urothelial Cancer, Bladder Cancer, Prostate Cancer, Prostatectomy, and Nephrectomy.

His clinical research consists of co-authoring 110 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Hydronephrosis.

Gender
Male

Locations

Sapporo, 0608638, Japan
Other Locations
Japan
Tokyo, Japan
Meguro, 1528551, Japan
Noda, 2788510, Japan
Tsukuba, 3003294, Japan
Maebashi, Japan
Urayasu, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: June 27, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib in Patients With Metastatic Castration-Resistant Prostate Cancer
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib in Patients With Metastatic Castration-Resistant Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: April 20, 2025
Intervention Type: Drug
Study Drugs: Abemaciclib, Abiraterone Acetate, Prednisone
Study Phase: Phase 2/Phase 3
View 1 Less Clinical Trial

109 Total Publications

Comparative evaluation of four reconstruction techniques for prostate T2-weighted MRI: Sensitivity encoding, compressed sensing, deep learning, and super-resolution.
Comparative evaluation of four reconstruction techniques for prostate T2-weighted MRI: Sensitivity encoding, compressed sensing, deep learning, and super-resolution.
Journal: European journal of radiology open
Published: July 11, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Matsumoto's expertise for a condition
ConditionClose
    View All 22 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile